Atlas Trials

Effect of Allopurinol or Febuxostat to Prevent Contrast Induced Acute Kidney Injury (CI-AKI)

Clinical trial NCT03767322 · UNKNOWN

Trial details

NCT number
NCT03767322
Sponsor
Instituto Nacional de Cardiologia Ignacio Chavez
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Contrast-induced NephropathyContrast-induced Acute Kidney Injury
Start date
2018-12-05
Primary completion
2019-10-01
Enrollment
558

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.